In an analysis of two large U.S. cohorts, higher olive oil intake was associated with lower risk of a composite of major CVD and CHD risk compared to those consuming olive oil <1 per month.
A review article published in JACC outlines CV considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic.
Using data from the MESA study, it was demonstrated that individuals with irregular sleep duration and timing have increased risk of CVD.
This viewpoint article draws attention towards acute and possible long-term implications of coronavirus infections, such as COVID-19, on the cardiovascular system.
The ESC Council on Hypertension has released a statement, strongly recommending to continue treatment of ACEi and ARBs in times of the COVID-19 pandemic, as evidence for harmful effects of these drugs in context of COVID-19 is lacking.
A community-based multicomponent intervention led to a greater reduction in BP than usual care among adults with hypertension in rural communities in three South Asian countries.
The ACC has released a clinical bulletin providing literature on acute cardiac complications of COVID-19, implications for CV patients and clinical guidance and recommendations for cardiac-specific preparedness.
This cluster randomized, non-inferiority trial showed that integrated care for elderly AF patients in a primary care setting led to a 45% reduction in all-cause mortality compared with usual care.
An analysis of the EUROASPIRE V survey showed that dysglycemia in CAD patients was unrecognized in a large portion of patients, while two thirds of CAD patients have T2DM or IGT.
High intake of sugar-sweetened beverages was associated with adverse changes in HDL-c and triglyceride, along with higher incidence of dyslipidemias related to low HDL-c and high triglyceride.
This multi-cohort study of Hispanic and non-Hispanic overweight/obese postmenopausal women shows that sitting behavior is deleteriously associated with higher levels of cardiometabolic risk biomarkers.
The Consensus Panel of the European Atherosclerosis Society has published a statement on key biological mechanisms that underlie the central role of LDL in the pathophysiology of ASCVD.